| Market Capitalization (Millions $) |
68 |
| Shares
Outstanding (Millions) |
53 |
| Employees |
54 |
| Revenues (TTM) (Millions $) |
- |
| Net Income (TTM) (Millions $) |
-75 |
| Cash Flow (TTM) (Millions $) |
-5 |
| Capital Exp. (TTM) (Millions $) |
0 |
Business Description
PMV Pharmaceuticals Inc is a clinical-stage biotechnology company focused on discovering and developing small molecule drugs that target p53, a tumor-suppressor protein that plays a key role in preventing the development and progression of cancer. The company was founded in 2013 by Dr. Arnold Levine and is headquartered in Cranbury, New Jersey.
PMV Pharma's lead product candidate, PMV-01, is a small molecule that restores the activity of mutant p53 proteins, which are found in over 50% of all human cancers. PMV Pharma is developing PMV-01 for the treatment of a variety of cancers, including ovarian, colorectal, breast, and lung cancers. PMV-01 has completed Phase 1 clinical trials and is currently in Phase 2 clinical trials.
The company has also developed a proprietary drug discovery platform called R-x Discovery, which uses high throughput screening and medicinal chemistry to identify and optimize small molecule drug candidates that target p5 Through this platform, PMV Pharma has identified several preclinical drug candidates that it plans to advance into clinical trials.
PMV Pharma has raised over $300 million in funding to date from a variety of sources, including venture capital firms, strategic investors, and public markets. The company went public in June 2020 and is traded on the NASDAQ under the ticker symbol PMVP.
The company is led by a team of experienced biotech executives, including CEO and President David Mack, who has over 20 years of experience in the pharmaceutical industry. PMV Pharma's board of directors includes several distinguished scientists and business leaders, including Dr. Arnold Levine, the company's founder and a professor of oncology at the Institute for Advanced Study in Princeton, New Jersey.
Overall, PMV Pharmaceuticals Inc is a leading biotech company that is focused on developing innovative cancer therapies that target p53, a key tumor-suppressor protein. With its proprietary drug discovery platform and experienced leadership team, PMV Pharma is well-positioned to make significant contributions to the field of cancer research and treatment in the years to come.
Company Address: 400 Alexander Park Drive Princeton 8540 NJ
Company Phone Number: 642-6670 Stock Exchange / Ticker: NASDAQ PMVP
|
